NewMed Energy - Limited Partnership
DKDRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.34 | -2.81 | 0.09 | -0.22 |
| FCF Yield | 12.07% | 13.20% | 15.36% | 15.75% |
| EV / EBITDA | 6.19 | 6.38 | 5.51 | 7.08 |
| Quality | ||||
| ROIC | 13.99% | 13.74% | 14.44% | 4.92% |
| Gross Margin | 63.20% | 74.90% | 61.34% | 58.71% |
| Cash Conversion Ratio | 1.10 | 1.29 | 1.07 | 1.12 |
| Growth | ||||
| Revenue 3-Year CAGR | -0.22% | 1.93% | 7.57% | 24.86% |
| Free Cash Flow Growth | 9.50% | 4.26% | -4.12% | 158.73% |
| Safety | ||||
| Net Debt / EBITDA | 1.80 | 2.29 | 2.46 | 3.03 |
| Interest Coverage | 6.31 | 5.47 | 4.63 | 2.28 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | -1.60 | 0.00 | -5.64 |
| Cash Conversion Cycle | 99.23 | -81.71 | 103.61 | 26.48 |